All Posts

At Fletcher, we’ve spent over 35 years helping companies win with deep, tailored research. But the world has changed. Teams are moving faster. Budgets are tighter. The appetite for drawn-out projects is shrinking...

With traditional IPO pathways staying tightly constrained, reverse mergers have shifted from a backup plan to a clear growth strategy across biopharma. Over the past two weeks alone, two high-profile deals highlighted how management teams are using creative capital structures to keep high-value pipelines moving.

For most of my career in competitive intelligence, the hardest part of the work was getting the information. Finding it, verifying it, and putting it in front of a decision maker before it went stale. That problem has not gone away, but it has changed shape. AI can now surface in seconds what used to take an analyst days. Which raises a new question for everyone in this field: if gathering is getting easier, what is the CI practitioner actually for?